申请人:Pan Shifeng
公开号:US20090306039A1
公开(公告)日:2009-12-10
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1,4,5-trisphosphate 3-kinase B (ITPKb).
本发明提供了一类新型化合物,包括这些化合物的药物组合物和使用这些化合物治疗或预防与异常或失调B细胞活性相关的疾病或疾病的方法,特别是那些涉及到肌醇1,4,5-三磷酸3-激酶B (ITPKb) 异常激活的疾病或疾病。